title: A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice.
abstract: The long pentraxin, pentraxin 3 (PTX3), can play beneficial or detrimental roles during infection and disease by modulating various aspects of the immune system. There is growing evidence to suggest that PTX3 can mediate antiviral activity in vitro and in vivo. Previous studies demonstrated that PTX3 and the short pentraxin serum amyloid P express sialic acids that are recognized by the hemagglutinin (HA) glycoprotein of certain influenza A viruses (IAV), resulting in virus neutralization and anti-IAV activity. In this study, we demonstrate that specificity of both HA and the viral neuraminidase for particular sialic acid linkages determines the susceptibility of H1N1, H3N2, and H7N9 strains to the antiviral activities of PTX3 and serum amyloid P. Selection of H3N2 virus mutants resistant to PTX3 allowed for identification of amino acid residues in the vicinity of the receptor-binding pocket of HA that are critical determinants of sensitivity to PTX3; this was supported by sequence analysis of a range of H3N2 strains that were sensitive or resistant to PTX3. In a mouse model of infection, the enhanced virulence of PTX3-resistant mutants was associated with increased virus replication and elevated levels of proinflammatory cytokines in the airways, leading to pulmonary inflammation and lung injury. Together, these studies identify determinants in the viral HA that can be associated with sensitivity to the antiviral activities of PTX3 and highlight its importance in the control of IAV infection.
authors.affiliation: Department of Microbiology and Immunology, University of Melbourne, Melbourne 3010, Victoria, Australia;
authors.forename: Emma R
authors.initials: ER
authors.lastname: Job
authors.forename: Barbara
authors.initials: B
authors.lastname: Bottazzi
authors.forename: Kirsty R
authors.initials: KR
authors.lastname: Short
authors.forename: Yi-Mo
authors.initials: YM
authors.lastname: Deng
authors.forename: Alberto
authors.initials: A
authors.lastname: Mantovani
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Brooks
authors.forename: Patrick C
authors.initials: PC
authors.lastname: Reading
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D002097:C-Reactive Protein / Q000008:administration & dosage / Q000494:pharmacology*; D002460:Cell Line; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D053122:Influenza A Virus, H3N2 Subtype / Q000187:drug effects* / Q000235:genetics* / Q000472:pathogenicity; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D009154:Mutation; D009439:Neuraminidase / Q000235:genetics / Q000378:metabolism; D009976:Orthomyxoviridae Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000821:virology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D016415:Sequence Alignment; D000683:Serum Amyloid P-Component / Q000008:administration & dosage / Q000494:pharmacology*; D014774:Virulence / Q000235:genetics; D000099153:Pentraxins
chemical_list: D002097:C-Reactive Protein; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D009439:Neuraminidase; D011994:Recombinant Proteins; D000683:Serum Amyloid P-Component; D000099153:Pentraxins